M. Kamaura

发表

Synthesis, structure-activity relationship, and pharmacological studies of novel melanin-concentrating hormone receptor 1 antagonists 3-aminomethylquinolines: reducing human ether-a-go-go-related gene (hERG) associated liabilities.

J. Kunitomo, Masaharu Nakayama, Koki Kato, 2012, Journal of medicinal chemistry.

Melanin-concentrating hormone receptor 1 antagonists. Synthesis and structure-activity relationships of novel 3-(aminomethyl)quinolines.

Koki Kato, Y. Nakano, Toshio Tanaka, 2012, Journal of medicinal chemistry.

Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor.

S. Nishimura, N. Amano, Rei Okamoto, 2020, Bioorganic & medicinal chemistry.

Discovery of phenylpyrrolidine derivatives as a novel class of retinol binding protein 4 (RBP4) reducers.

A. Mizukami, N. Cho, S. Kasai, 2021, Bioorganic & medicinal chemistry.

Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.

K. Ogawa, T. Kawamoto, Rei Okamoto, 2017, European journal of medicinal chemistry.

Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials.

David M. Shackleford, Laura M Sanz, K. Dechering, 2021, Journal of medicinal chemistry.

Discovery of Novel 5-(Piperazine-1-carbonyl)pyridin-2(1H)-one Derivatives as Orally eIF4A3-Selective Inhibitors.

K. Fukuda, Y. Imaeda, Y. Kosugi, 2017, ACS medicinal chemistry letters.

Extreme thermal stability of disodium 9-fluorenone dianion as a practical indicator for the preparation of absolute THF

M. Kamaura, J. Inanaga, 1999 .

PREPARATION AND UTILITY OF NOVEL WATER-TOLERANT HIGHER-ORDER LANTHANOID ALKOXIDE COMPLEXES AS A BASE CATALYST

T. Hanamoto, M. Kamaura, J. Inanaga, 1998 .

Remarkable ligand effect on the enantioselectivity of the chiral lanthanum complex-catalyzed asymmetric epoxidation of enones

M. Kamaura, J. Inanaga, Kazuhiro Daikai, 1998 .

Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists.

Kenjiro Sato, H. Imoto, M. Kamaura, 2014, Bioorganic & medicinal chemistry.

Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.

S. Sogabe, Tomoya Sameshima, M. Kamaura, 2017, ACS medicinal chemistry letters.

Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging.

Kotaro Sakamoto, Tomoya Sameshima, M. Kamaura, 2017, Bioorganic & medicinal chemistry letters.

Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.

Koki Kato, Y. Nakano, M. Tawada, 2011, Bioorganic & medicinal chemistry.

Discovery of a Novel Series of N-Phenylindoline-5-sulfonamide Derivatives as Potent, Selective, and Orally Bioavailable Acyl CoA:Monoacylglycerol Acyltransferase-2 Inhibitors.

Tsuyoshi Ishii, Kenjiro Sato, N. Amano, 2015, Journal of medicinal chemistry.

K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology.

Kotaro Sakamoto, S. Ohkubo, Tomoya Sameshima, 2017, Biochemical and biophysical research communications.

Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives.

Kenjiro Sato, S. Iwasaki, Koji Watanabe, 2021, Bioorganic & medicinal chemistry.

Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities.

Kazumi Take, Kenjiro Sato, N. Amano, 2015, Bioorganic & medicinal chemistry.

Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection

O. Engkvist, G. Pairaudeau, David Shum, 2023, Journal of medicinal chemistry.

Melanin-concentrating hormone receptor 1 antagonists: synthesis, structure-activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives.

Koki Kato, Y. Nakano, M. Tawada, 2011, Bioorganic & Medicinal Chemistry.

Discovery of a novel series of indolinylpyrimidine-based GPR119 agonists: Elimination of ether-a-go-go-related gene liability using a hydrogen bond acceptor-focused approach.

Kenjiro Sato, S. Iwasaki, M. Kamaura, 2021, Bioorganic & medicinal chemistry.

Discovery of a novel series of medium-sized cyclic enteropeptidase inhibitors.

Sachiko Itono, K. Fukuda, Naohiro Taya, 2023, Bioorganic & medicinal chemistry.